0.5 ML buprenorphine 200 MG/ML Prefilled Syringe — RxCUI 1996184
RxNorm drug concept · Semantic clinical drug
RxCUI 1996184
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1996184
Official name0.5 ML buprenorphine 200 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbuprenorphine 100 MG per 0.5 ML Prefilled Syringe; buprenorphine 100 MG in 0.5 mL Prefilled Syringe
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)335,124 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Buprenorphine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No, the buprenorphine transdermal patch is specifically for managing severe, persistent pain that needs continuous, around-the-clock treatment over an extended period. It's prescri...
- What is this patch actually for — is it for addiction treatment?
- Each patch is worn on your skin for 7 days before being swapped out. You apply it to clean, dry, intact skin on your upper outer arm, upper chest, upper back, or side of the chest....
- How do I apply the patch, and how long does each one last?
🕸️ Concept Web — How 0.5 ML buprenorphine 200 MG/ML Prefilled Syringe Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
0.5 ML buprenorphine 200 MG/ML Prefilled Syringe
RxCUI 1996184 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Buprenorphine
1819IN
-
Buprenorphine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sublocade
1996185BN
-
Sublocade
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Buprenorphine Prefilled Syringe
1996183SCDF -
Buprenorphine Injectable Product
1151361SCDG -
Buprenorphine Prefilled Syringe [Sublocade]
1996187SBDF -
Sublocade Injectable Product
1996188SBDG -
Prefilled Syringe
721656DF -
Injectable Product
1151126DFG
-
Buprenorphine Prefilled Syringe
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Buprenorphine 200 MG/ML
1996182SCDC -
0.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]
1996189SBD -
Buprenorphine 200 MG/ML [Sublocade]
1996186SBDC
-
Buprenorphine 200 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Buprenorphine 200 MG/ML
SCDC · 1996182 -
Buprenorphine Prefilled Syringe
SCDF · 1996183 -
Buprenorphine Injectable Product
SCDG · 1151361
Brand-Name Concepts
-
0.5 ML buprenorphine 200 MG/ML Prefilled Syringe [Sublocade]
SBD · 1996189 -
Buprenorphine 200 MG/ML [Sublocade]
SBDC · 1996186 -
Buprenorphine Prefilled Syringe [Sublocade]
SBDF · 1996187 -
Sublocade Injectable Product
SBDG · 1996188 -
Sublocade
BN · 1996185
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 1996184 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 12496-0100-01 | 1 POUCH in 1 CARTON (12496-0100-1) / 1 SYRINGE in 1 POUCH (... | SUBLOCADE | Indivior Inc. | 2018-02-26 |
| 12496-0300-01 | 1 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (... | SUBLOCADE | Indivior Inc. | 2018-02-26 |
Observed labelers:
Indivior Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| Q9991 | Buprenorph xr 100 mg or less | 1 | CMS |
| Q9992 | Buprenorphine xr over 100 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.